Eugene Manley
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Nephrology top 1%
Papers in
- Aging 1
-
- Chemical Reactions and Isotopes 2
- Co-authors
- Charles FoxHonora H. McElroyR R HolmanDonna WrightMichael GnantIrene StrattonC A CullMatthews
- Journals
- Frontiers in Oncology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)BMJ Open (1 paper)Cancer Letters (1 paper)Journal of Bone and Mineral Research (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Eugene Manley
11 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Endocrinology, Diabetes and Metabolism 5.3k
- Nephrology 403
- Family Practice 124
- Ophthalmology 484
- Clinical Biochemistry 313
Countries citing papers authored by Eugene Manley
This map shows the geographic impact of Eugene Manley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Manley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Manley more than expected).
Fields of papers citing papers by Eugene Manley
This network shows the impact of papers produced by Eugene Manley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Manley. The network helps show where Eugene Manley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eugene Manley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 0 | |
| 6 | 2019 | 6 | |
| 7 | 2017 | 7 | |
| 8 | 2015 | 9 | |
| 9 | 2013 | 5 | |
| 10 | 2012 | 12 | |
| 11 | 2010 | 1 | |
| 12 | 2003 | 7 | |
| 13 | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Hit paper breakdown → | 1998 | 7180 |
About Eugene Manley
Eugene Manley is a scholar working on Aging, Pharmaceutical Science, Cancer Research, Orthopedics and Sports Medicine and Oncology, having authored 13 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Global Cancer Incidence and Screening (2 papers), Connective tissue disorders research (2 papers), Cancer Cells and Metastasis (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Chemical Reactions and Isotopes (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.3k citations), Nephrology (403 citations), Family Practice (124 citations), Ophthalmology (484 citations) and Clinical Biochemistry (313 citations). Eugene Manley has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Charles Fox, Honora H. McElroy, R R Holman, Donna Wright, Michael Gnant, Irene Stratton, C A Cull, Matthews, E M Kohner and David R. Hadden. Their work appears in journals such as Frontiers in Oncology, Journal of Pharmacology and Experimental Therapeutics, BMJ Open, Cancer Letters and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.